Activation of the PI3K/AKT/mTOR signaling cascade prevents the GCR from translocation to the nucleus and it is the activation of AKT1 that may play a role in the development of GC resistance in ALL [36]. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.